BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7105 related articles for article (PubMed ID: 1879040)

  • 1. Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine).
    Narita T; Koide Y; Yaguchi S; Kimura S; Izumisawa Y; Takase M; Inaba M; Tsukagoshi S
    Cancer Chemother Pharmacol; 1991; 28(4):235-40. PubMed ID: 1879040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
    Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
    Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f: potent antitumor activities in various murine tumor models.
    Kumazawa E; Ochi Y
    Cancer Sci; 2004 Feb; 95(2):168-75. PubMed ID: 14965368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of daunomycin and melanotropin-daunomycin with DNA.
    Weisehahn G; Varga JM; Hearst JE
    Nature; 1981 Jul; 292(5822):467-9. PubMed ID: 7254342
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor and tissue pharmacokinetics of cytostatic drugs in the nude mouse.
    Scheulen ME; Budach V; Bamberg M
    Strahlenther Onkol; 1989 Jul; 165(7):529-32. PubMed ID: 2473533
    [No Abstract]   [Full Text] [Related]  

  • 6. Interference by cellular melanin with assay of DNA-protein crosslinks by the potassium dodecyl sulfate precipitation method.
    Goodman RM; Hill HZ
    Pigment Cell Res; 1996 Apr; 9(2):68-71. PubMed ID: 8857668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the differentiated state in somatic cell hybrids.
    Davidson RL
    Symp Soc Dev Biol; 1973; 31():295-328. PubMed ID: 4205817
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes.
    Chakraborty NG; Sporn JR; Pasquale DR; Ergin MT; Mukherji B
    Clin Immunol Immunopathol; 1991 Jun; 59(3):407-16. PubMed ID: 2029793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of three distinct biologically active type C viruses from cloned C57Bl/6 melanoma cells.
    Levy JA; Rutledge F; Dimpfl J; Silagi S
    J Gen Virol; 1979 May; 43(2):283-8. PubMed ID: 225423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of skeletal metastases in 31 melanoma patients.
    Wedin R; Falkenius J; Weiss RJ; Hansson J
    Acta Orthop Belg; 2012 Apr; 78(2):246-53. PubMed ID: 22696997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic in vivo cancer models: three examples of mouse models used in experimental therapeutics.
    Kruczynski A; Hill BT
    Curr Protoc Pharmacol; 2002 Feb; Chapter 5():Unit5.24. PubMed ID: 21959766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UV-induced N-ras mutations are T-cell targets in human melanoma.
    van Elsas A; Scheibenbogen C; van der Minne C; Zerp SF; Keilholz U; Schrier PI
    Melanoma Res; 1997 Aug; 7 Suppl 2():S107-13. PubMed ID: 9578425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower frequency of sister chromatid exchanges and altered frequency of HLA B-region alleles among individuals with sporadic dysplastic nevi.
    Illeni MT; Rovini D; Di Lernia M; Cascinelli N; Ghidoni A
    Int J Biol Markers; 1997; 12(3):118-24. PubMed ID: 9479594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
    Desai PB; Duan J; Sridhar R; Damle BD
    Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo tumor growth suppression by HIV-1 Vpr.
    Mahalingam S; MacDonald B; Ugen KE; Ayyavoo V; Agadjanyan MG; Williams WV; Weiner DB
    DNA Cell Biol; 1997 Feb; 16(2):137-43. PubMed ID: 9052734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of interleukin 12 to antitumor cytokine and gene therapy.
    Nishimura T; Watanabe K; Yahata T; Ushaku L; Ando K; Kimura M; Saiki I; Uede T; Habu S
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S27-34. PubMed ID: 8765412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant BCG therapy suppresses melanoma tumor growth.
    Duda RB; Yang H; Dooley DD; Abu-Jawdeh G
    Ann Surg Oncol; 1995 Nov; 2(6):542-9. PubMed ID: 8591086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labial melanotic macule: a clinical, histopathologic, and ultrastructural study.
    Ho KK; Dervan P; O'Loughlin S; Powell FC
    J Am Acad Dermatol; 1993 Jan; 28(1):33-9. PubMed ID: 8425968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple intracranial melanoma metastases treated with surgery and radiosurgery with long term control. A case report.
    Fedorcsák I; Sipos L; Horváth A; Kontra G; Bognár L; Osztie E
    J Neurooncol; 1993 May; 16(2):173-6. PubMed ID: 8289095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solar radiation in the etiology of cutaneous malignant melanoma in Caucasians.
    Elwood JM; Hislop TG
    Natl Cancer Inst Monogr; 1982; 62():167-71. PubMed ID: 7167183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 356.